GGPS1

GGPS1 encodes geranylgeranyl diphosphate (GGPP) synthase, a prenyltransferase that supplies the isoprenoid lipid anchor essential for membrane association and function of small GTPases across multiple tissue contexts. The enzyme catalyzes the condensation of farnesyl diphosphate and isopentenyl diphosphate to produce GGPP, which serves as the obligate substrate for geranylgeranylation of Rab and Rho family GTPases, thereby controlling processes including RhoA/Rock2-dependent uterine smooth muscle contraction, Rab10-mediated TLR4 trafficking and NLRP3 inflammasome activation, Rab37-dependent autophagy, BMP2/Smad/Runx2 signaling in chondrocytes during endochondral ossification, and plasma membrane repair in skeletal muscle (PMID:10101267, PMID:33340314, PMID:30652497, PMID:35334098, PMID:28357594, PMID:32403198). Biallelic loss-of-function variants in GGPS1 cause muscular dystrophy with hearing loss and ovarian insufficiency, and patient-derived myogenic cells exhibit defective membrane resealing, while a homozygous knock-in mouse model is prenatally lethal (PMID:32403198).

1. 1999 High

   Establishing the basic enzymatic identity of GGPS1 resolved what gene product synthesizes GGPP in mammals, providing the foundation for all subsequent pathway studies.

   Evidence Heterologous expression in E. coli with in vitro enzyme activity assay and carotenoid biosynthesis complementation

   PMID:10101267

   Open questions at the time

   • No structural information on the human enzyme
   • Tissue-specific roles of GGPP supply not addressed
   • Relative contribution versus other isoprenoid pathways not determined
2. 2017 Medium

   Chondrocyte-specific deletion revealed that GGPS1-derived GGPP normally restrains BMP2/Smad/Runx2 signaling, answering how the mevalonate pathway regulates endochondral ossification.

   Evidence Tamoxifen-inducible Col2-CreERT2 Ggps1 conditional knockout mice with histological and molecular pathway analysis

   PMID:28357594

   Open questions at the time

   • Specific small GTPase(s) mediating BMP2 suppression in chondrocytes not identified
   • Single-lab finding not independently replicated
   • Whether pharmacological GGPP supplementation rescues the phenotype not tested
3. 2019 Medium

   Lung-specific knockout linked GGPS1 to innate immune signaling by showing that GGPP-dependent Rab10 geranylgeranylation is required for TLR4 membrane localization and downstream NLRP3 inflammasome activation.

   Evidence Lung-specific GGPPS1 knockout mouse with Western blot for Rab10 membrane localization, TLR4, and NLRP3/IL-1β readouts

   PMID:30652497

   Open questions at the time

   • Causal link relies on inference from GGPP loss rather than direct reconstitution with geranylgeranylated Rab10
   • Whether other Rab GTPases contribute to TLR4 trafficking in this context not examined
4. 2020 High

   Identification of biallelic GGPS1 mutations in patients with muscular dystrophy, hearing loss, and ovarian insufficiency established GGPS1 as a Mendelian disease gene and revealed that GGPP-dependent prenylation is required for muscle membrane repair.

   Evidence Whole-exome sequencing of affected families; laser injury assay on patient-derived myogenic cells; Y259C knock-in mouse showing prenatal lethality

   PMID:32403198

   Open questions at the time

   • Specific small GTPase(s) responsible for membrane resealing downstream of GGPS1 not identified
   • Mechanism of hearing loss and ovarian insufficiency not dissected at the molecular level
5. 2021 High

   Myometrial-specific deletion demonstrated that GGPS1 is essential for parturition by supplying GGPP for RhoA geranylgeranylation, activating the RhoA/Rock2/p-MLC contractile pathway — the first complete pathway reconstitution from GGPS1 to a physiological output with biochemical rescue.

   Evidence Myometrial Ggps1 conditional knockout mice; assessment of RhoA prenylation, Rock2, and p-MLC; GGPP supplementation rescue

   PMID:33340314

   Open questions at the time

   • Whether other prenylated GTPases contribute to myometrial contraction alongside RhoA not resolved
   • Relevance to human labor and potential therapeutic GGPP supplementation not tested
6. 2022 Medium

   Placing Rab37 downstream of GGPS1 in autophagy regulation extended the effector repertoire beyond Rab10 and RhoA, answering how GGPS1 loss suppresses autophagy in lung injury.

   Evidence Lung-specific GGPPS1 KO mice and RAW264.7 knockdown cells with Rab37 overexpression rescue; TEM of autophagosomes

   PMID:35334098

   Open questions at the time

   • Whether Rab37 geranylgeranylation specifically (versus expression level) is the regulated step is unclear
   • Single-lab finding in one cell type and tissue context
7. 2023 Medium

   Identification of the circUBR1/miR-20a-5p axis targeting GGPPS1 mRNA provided the first validated post-transcriptional regulatory mechanism for GGPS1 expression.

   Evidence circUBR1 knockdown in VILI mouse model and alveolar epithelial cells; miR-20a-5p target validation; GGPPS1 overexpression rescue

   PMID:37827345

   Open questions at the time

   • Physiological relevance of circRNA-mediated regulation beyond the VILI context unknown
   • Direct miR-20a-5p binding site mutagenesis on GGPS1 3'UTR not shown in this study

• A comprehensive map of which specific small GTPases mediate each tissue-specific phenotype of GGPS1 loss — and whether GGPS1 has non-catalytic functions — remains to be established.
• No structural model of human GGPS1 validated experimentally
• Substrate channeling or protein–protein interactions beyond catalysis not investigated
• Genotype–phenotype correlation for different GGPS1 mutations in Mendelian disease not systematically characterized